StreetInsider.com News Articles

Form 4 Orchestra BioMed Holding For: Jun 01 Filed by: Hochman David P

Tue, 02 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260602/26592159.html

Form 4 Orchestra BioMed Holding For: Jun 01 Filed by: Hochman David P

Tue, 02 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260602/26592159.html

Form 4 Orchestra BioMed Holding For: Jun 01 Filed by: Sherman Darren

Tue, 02 Jun 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260602/26592127.html

Form 4 Orchestra BioMed Holding For: Jun 01 Filed by: Sherman Darren

Tue, 02 Jun 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260602/26592127.html

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 02 Jun 2026 16:05:00 -0400

NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on June 1, 2026, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 85,500 shares of the Company’s common stock to five newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 02 Jun 2026 16:05:00 -0400

Form 144 Orchestra BioMed Holding Filed by: Sherman Darren

Mon, 01 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260601/26583890.html

Form 144 Orchestra BioMed Holding Filed by: Sherman Darren

Mon, 01 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260601/26583890.html

Form 4 Orchestra BioMed Holding For: May 28 Filed by: Taylor Andrew Lawrence

Fri, 29 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260529/26575410.html

Form 4 Orchestra BioMed Holding For: May 28 Filed by: Taylor Andrew Lawrence

Fri, 29 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260529/26575410.html

Form 4 Orchestra BioMed Holding For: May 28 Filed by: Sherman Darren

Fri, 29 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260529/26575373.html

Form 4 Orchestra BioMed Holding For: May 28 Filed by: Sherman Darren

Fri, 29 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260529/26575373.html

Form 4 Orchestra BioMed Holding For: May 18 Filed by: Aryeh Jason

Wed, 20 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260520/26525084.html

Form 4 Orchestra BioMed Holding For: May 18 Filed by: Aryeh Jason

Wed, 20 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260520/26525084.html

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

Tue, 19 May 2026 08:30:00 -0400

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will be participating in the Jefferies Global Healthcare Conference.

Chairman and CEO David Hochman will participate in a fireside chat with Matt Taylor, Managing Director at Jefferies at 9:55am ET on Thursday June 4, 2026 and will also host one-on-one meetings with investors that day and on Wednesday, June 3. The fireside chat will be accessible to investors

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

Tue, 19 May 2026 08:30:00 -0400

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

Tue, 19 May 2026 08:30:00 -0400

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

Tue, 19 May 2026 08:30:00 -0400

Orchestra BioMed Inc. (OBIO) PT Lowered to $10 at B.Riley

Tue, 19 May 2026 08:22:50 -0400

B.Riley analyst Kyle Bauser lowered the price target on Orchestra BioMed Inc. (NASDAQ: OBIO) to $10.00 (from $12.00) while maintaining a Buy rating.

Form 4 Orchestra BioMed Holding For: May 15 Filed by: Hochman David P

Tue, 19 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260519/26517560.html

Form 4 Orchestra BioMed Holding For: May 15 Filed by: Hochman David P

Tue, 19 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260519/26517560.html

Form 4 Orchestra BioMed Holding For: May 15 Filed by: Aryeh Jason

Tue, 19 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260519/26517561.html

Form 4 Orchestra BioMed Holding For: May 15 Filed by: Aryeh Jason

Tue, 19 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260519/26517561.html

Form 4 Orchestra BioMed Holding For: May 14 Filed by: Fain Eric S

Mon, 18 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260518/26510439.html

Form 4 Orchestra BioMed Holding For: May 14 Filed by: Fain Eric S

Mon, 18 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260518/26510439.html